In the Journals

Newly diagnosed cases of AS at increased risk for IMIDs, lower risk for RA

September 16, 2019
Newly diagnosed patients with ankylosing spondylitis in Taiwan demonstrate increased risks for multiple immune-mediated inflammatory diseases…
Meeting News

Minimizing decision ‘uncertainty’ key to successful practice management

September 16, 2019
GRAND RAPDIS, Mich. — Successful management in rheumatology practices requires both evidence-based approaches and critical thinking, in order…
Meeting News

Generation Z ‘coming soon to a workforce near you’ – Are you ready?

September 13, 2019
GRAND RAPIDS, Mich. — Workplaces and managers who may or may not have just grown acquainted with — and successfully integrated —…
In the Journals

Patients with low-disease RA on tofacitinib, methotrexate can safely withdraw methotrexate

September 12, 2019
Patients with rheumatoid arthritis who achieve low disease activity with tofacitinib plus methotrexate can safely withdraw methotrexate without fear…
Feature

Purdue Pharma tentatively settles opioid lawsuits, others still pending

September 12, 2019
Oxycontin manufacturer Purdue Pharma recently reached a tentative agreement with many of the thousands of plaintiffs involved in a multidistrict…
In the Journals

Stress ‘primary driver’ for fatigue in patients with SLE

September 12, 2019
Although depression and stress are both predictors of fatigue among patients with systemic lupus erythematosus at 1 year, stress is the…
Breaking News

‘Progress being made’ in opioid epidemic, CDC says

September 12, 2019
A CDC spokesperson said provisional data and other reports signify that “progress is being made” in the opioid epidemic. The turnaround…

370 medical groups petition Congress for prior authorization reform

September 11, 2019
The American College of Rheumatology has joined 369 other patient, physician and health care professional groups in calling on Congress to pass a…
In the Journals

Quarter of axial SpA patients attain inactive disease after 6 months on first TNF inhibitor

September 11, 2019
Among patients with axial spondyloarthritis receiving their first TNF inhibitor, 27% achieve inactive disease, defined by the Ankylosing Spondylitis…

Advocates lobby for bills to reform step therapy, expand rheumatology workforce

September 10, 2019
More than 100 patient advocates, including physicians and health professionals from the American College of Rheumatology, took to Capitol Hill this…
In the Journals

Patient-reported symptoms linked to disease activity changes in SSc

September 10, 2019
Patient-reported symptoms are associated with clinically impactful changes in systemic sclerosis disease activity, according to findings published in…
In the Journals

Number of prior DMARDs, disease duration linked to diminished drug response in RA

September 9, 2019
Longer disease duration and a greater number of previous DMARDs in a patient’s history is associated with decreased response rates to…
In the JournalsPerspective

Patients with gout have 30% higher risk for chronic kidney disease

September 9, 2019
Gout is associated with a 29% increased risk for developing advanced chronic kidney disease and a 210% increased risk for end-stage renal disease…
FDA News

FDA approves nintedanib for systemic sclerosis-associated ILD

September 6, 2019
The FDA has approved nintedanib capsules to slow the rate of decline in pulmonary function in adults with interstitial lung disease associated with…

ACR: CVS-Aetna merger threatens efforts to lower drug costs

September 6, 2019
The American College of Rheumatology issued a warning on Friday that a U.S. District Court judge’s decision to allow CVS Health Corp to merge…
Q&A With Healio Rheumatology

For IBD-associated arthritis, disease control is becoming a team sport

September 6, 2019
Rheumatologists are generally familiar with complicated case patients who require management across specialties. The same goes for…
In the JournalsPerspective

Telemedicine more commonly used by patients with higher RA activity

September 5, 2019
Video telemedicine, when it is offered, is more likely to be used by patients with rheumatoid arthritis who demonstrate higher disease activity, have…

AMA says judge’s decision to allow CVS-Aetna merger ‘fails patients’

September 5, 2019
The AMA expressed disappointment over a federal judge allowing CVS Health Corp to merge with Aetna. CNBC and other mainstream media reported…
In the JournalsPerspective

Adalimumab well-tolerated by most children with polyarticular JIA

September 5, 2019
Adalimumab, with or without methotrexate, is well-tolerated over a period of at least 7 years among most children with polyarticular-course juvenile…
In the Journals

Golimumab efficacy in RA similar for patients older, younger than 65 years

September 4, 2019
IV golimumab, combined with methotrexate, is as efficacious among patients with rheumatoid arthritis who are aged 65 years and older as it is among…